Comparison of the transcript-per-million values in normal and primary tumor tissues verified PRDX2 overexpression in BRCA, CHOL, LIHC, LUAD, PRAD and UCEC (Figure 1B). This evidence concerns the gene PRDX2 and neoplasm.